Profile | GDS4284 / 231852_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 420.619 | 61 |
GSM687648 | Patient 402 control | 428.385 | 61 |
GSM687653 | Patient 403 control | 472.427 | 64 |
GSM687658 | Patient 404 control | 208.282 | 49 |
GSM687663 | Patient 411 control | 352.179 | 57 |
GSM687668 | Patient 422 control | 455.553 | 62 |
GSM687673 | Patient 424 control | 567.869 | 65 |
GSM687678 | Patient 425 control | 421.166 | 60 |
GSM687683 | Patient 427 control | 431.129 | 60 |
GSM687688 | Patient 428 control | 536.729 | 65 |
GSM687695 | Patient 441 control | 455.322 | 59 |
GSM687699 | Patient 443 control | 414.575 | 59 |
GSM687704 | Patient 444 control | 424.175 | 61 |
GSM687707 | Patient 448 control | 352.761 | 57 |
GSM687712 | Patient 449 control | 463.366 | 62 |
GSM687719 | Patient 450 control | 271.415 | 51 |
GSM687724 | Patient 451 control | 411.808 | 60 |
GSM687728 | Patient 452 control | 262.12 | 53 |
GSM687646 | Patient 401 treated 24h | 404.127 | 60 |
GSM687649 | Patient 402 treated 24h | 553.555 | 65 |
GSM687665 | Patient 411 treated 24h | 457.983 | 61 |
GSM687651 | Patient 402 treated 4 weeks | 271.563 | 53 |
GSM687667 | Patient 411 treated 4 weeks | 406.24 | 60 |
GSM687670 | Patient 422 treated 24h | 446.899 | 61 |
GSM687671 | Patient 422 treated 4 weeks | 396.493 | 60 |
GSM687654 | Patient 403 treated 24h | 504.184 | 64 |
GSM687675 | Patient 424 treated 24h | 464.876 | 62 |
GSM687685 | Patient 427 treated 24h | 246.688 | 52 |
GSM687656 | Patient 403 treated 4 weeks | 527.331 | 65 |
GSM687677 | Patient 424 treated 4 weeks | 312.582 | 56 |
GSM687687 | Patient 427 treated 4 weeks | 323.207 | 57 |
GSM687692 | Patient 428 treated 4h | 503.36 | 63 |
GSM687716 | Patient 449 treated 4h | 301.952 | 57 |
GSM687722 | Patient 450 treated 4h | 287.677 | 53 |
GSM687680 | Patient 425 treated 24h | 393.27 | 60 |
GSM687690 | Patient 428 treated 24h | 525.182 | 65 |
GSM687700 | Patient 443 treated 24h | 313.288 | 51 |
GSM687705 | Patient 444 treated 24h | 277.171 | 56 |
GSM687714 | Patient 449 treated 24h | 465.402 | 63 |
GSM687721 | Patient 450 treated 24h | 227.864 | 47 |
GSM687682 | Patient 425 treated 4 weeks | 292.008 | 56 |
GSM687694 | Patient 428 treated 4 weeks | 585.333 | 66 |
GSM687702 | Patient 443 treated 4 weeks | 626.32 | 66 |
GSM687718 | Patient 449 treated 4 weeks | 367.762 | 59 |
GSM687723 | Patient 450 treated 4 weeks | 246.158 | 51 |
GSM687661 | Patient 404 treated 4h | 297.472 | 54 |
GSM687710 | Patient 448 treated 4h | 367.858 | 59 |
GSM687726 | Patient 451 treated 4h | 476.758 | 62 |
GSM687730 | Patient 452 treated 4h | 141.834 | 28 |
GSM687660 | Patient 404 treated 24h | 375.882 | 58 |
GSM687697 | Patient 441 treated 24h | 342.629 | 54 |
GSM687709 | Patient 448 treated 24h | 337.504 | 57 |
GSM687725 | Patient 451 treated 24h | 576.901 | 65 |
GSM687729 | Patient 452 treated 24h | 214.155 | 43 |
GSM687727 | Patient 451 treated 4 weeks | 390.646 | 59 |
GSM687731 | Patient 452 treated 4 weeks | 611.925 | 66 |